X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (89) 89
index medicus (80) 80
patients receiving imatinib (67) 67
oncology (55) 55
hematology (52) 52
chronic myelogenous leukemia (49) 49
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (45) 45
chronic myeloid leukemia (44) 44
imatinib mesylate (42) 42
follow-up (40) 40
male (40) 40
female (38) 38
pyrimidines - therapeutic use (38) 38
antineoplastic agents - therapeutic use (35) 35
piperazines - therapeutic use (35) 35
protein kinase inhibitors - therapeutic use (32) 32
adult (31) 31
benzamides (31) 31
middle aged (30) 30
chronic-phase (29) 29
treatment outcome (29) 29
aged (28) 28
imatinib (28) 28
antineoplastic agents - adverse effects (25) 25
chronic myeloid-leukemia (24) 24
cancer (23) 23
leukemia (22) 22
pyrimidines - adverse effects (20) 20
care and treatment (19) 19
young adult (19) 19
bcr-abl (18) 18
hematology, oncology and palliative medicine (18) 18
prognosis (18) 18
cml (17) 17
dasatinib (17) 17
hemic and lymphatic diseases (17) 17
leukemia, myelogenous, chronic, bcr-abl positive - genetics (17) 17
adolescent (16) 16
interferon-alpha (16) 16
medicine & public health (16) 16
piperazines - adverse effects (16) 16
tyrosine kinase inhibitors (16) 16
antineoplastic agents - administration & dosage (15) 15
interferon (14) 14
pyrimidines - administration & dosage (14) 14
aged, 80 and over (13) 13
health aspects (13) 13
nilotinib (13) 13
pharmacology & pharmacy (13) 13
drug therapy (12) 12
fusion proteins, bcr-abl - genetics (12) 12
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (12) 12
leukemia, myelogenous, chronic, bcr-abl positive - mortality (12) 12
protein kinase inhibitors - adverse effects (12) 12
quality of life (12) 12
risk factors (12) 12
therapy (12) 12
tyrosine kinase inhibitor (12) 12
analysis (11) 11
low-dose cytarabine (11) 11
piperazines - administration & dosage (11) 11
stem-cell transplantation (11) 11
tyrosine (11) 11
benzamides - therapeutic use (10) 10
cytogenetic responses (10) 10
medicine, general & internal (10) 10
research (10) 10
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
article (9) 9
bone-marrow-transplantation (9) 9
chemotherapy (9) 9
clinical trials as topic (9) 9
leukemia, myeloid, chronic-phase - drug therapy (9) 9
medical research (9) 9
neoplasms (9) 9
philadelphia-chromosome (9) 9
protein-tyrosine kinases - antagonists & inhibitors (9) 9
receiving induction chemotherapy (9) 9
survival (9) 9
survival analysis (9) 9
transplantation (9) 9
antineoplastic agents (8) 8
child (8) 8
children (8) 8
clinical trials (8) 8
diagnosed chronic-phase (8) 8
drug resistance, neoplasm (8) 8
follow-up studies (8) 8
internal medicine (8) 8
leukemia, myelogenous, chronic, bcr-abl positive - therapy (8) 8
molecular response (8) 8
protein kinase inhibitors - administration & dosage (8) 8
receiving imatinib (8) 8
retrospective studies (8) 8
survival rate (8) 8
thiazoles - therapeutic use (8) 8
acute lymphoblastic-leukemia (7) 7
age factors (7) 7
alpha plus cytarabine (7) 7
disease-free survival (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 12/2018, Volume 65, Issue 12, pp. e27423 - n/a
Journal Article
International Immunopharmacology, ISSN 1567-5769, 09/2017, Volume 50, p. 69
C5BL/6 female mice receiving dextran sodium sulfate in their drinking water develop an acute inflammatory colitis within 7 d, with weight loss, histopathologic... 
Drinking water | Furfural | Liver | Medical services | Animal diseases | Chains | Hydroxyurea | Receiving waters | Histopathology | Rodents | Sodium sulfate | Hemoglobin | Attenuation | Glutathione | Immune system | Immune response | Cytokines | Fetuses | Inflammation | Rapamycin | Chemical compounds | Dextran | Overexpression | Animals | Sodium | Reagents | Mice | Sulfate | Colitis | Conformation
Journal Article
International Journal of Hematology, ISSN 0925-5710, 11/2017, Volume 106, Issue 5, pp. 591 - 611
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s12185-017-2330-1 Byline:... 
Medicine & Public Health | Hematology | Oncology | RISK ESSENTIAL THROMBOCYTHEMIA | PLUS INTERFERON-ALPHA | DIAGNOSED CHRONIC-PHASE | COMPLETE MOLECULAR REMISSION | STANDARD-DOSE IMATINIB | TYROSINE KINASE INHIBITOR | PATIENTS RECEIVING IMATINIB | STEM-CELL TRANSPLANTATION | HEMATOLOGY | CHRONIC MYELOID-LEUKEMIA | INTERNATIONAL WORKING GROUP | Prognosis | Humans | Imidazoles - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Risk | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - therapy | Antineoplastic Agents - administration & dosage | Quinolines - administration & dosage | Myeloproliferative Disorders - genetics | Aspirin - administration & dosage | Nitriles - administration & dosage | Blood Transfusion | Pyridazines - administration & dosage | Quinazolines - administration & dosage | Aniline Compounds - administration & dosage | Myeloproliferative Disorders - therapy | Pyrimidines - administration & dosage | Japan | Myeloproliferative Disorders - classification | Phlebotomy | Hematopoietic Stem Cell Transplantation | Hydroxyurea - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification | Pyrazoles - administration & dosage | Algorithms | Dasatinib - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Tumors | Myeloid leukemia | Leukemia | Chronic myeloid leukemia | Lymphoid tissue | Tissues | Neoplasms | Hemopoiesis
Journal Article
Journal Article
ONKOLOGE, ISSN 0947-8965, 01/2010, Volume 16, Issue 1, pp. 67 - 72
Chronic myeloid leukemia (CML) is a life-threatening disease. The introduction of imatinib, a tyrosine kinase inhibitor, substantially improved the prognosis... 
SURVIVAL | Imatinib | CML | CHRONIC-PHASE | PROGNOSIS | Hydroxyurea | Tolerability | Elderly patients | BUSULFAN | TRANSPLANTATION | INTERFERON | ONCOLOGY | PATIENTS RECEIVING IMATINIB | MESYLATE THERAPY | AGE
Journal Article
Medical and Pediatric Oncology, ISSN 0098-1532, 07/1996, Volume 27, Issue 1, pp. 26 - 31
Journal Article
Klinische Pädiatrie, ISSN 0300-8630, 11/2009, Volume 221, Issue 6, pp. 351 - 357
Abstract PURPOSE: Stem cell transplantation (SCT) can definitely cure chronic myeloid leukemia (CML), a rare disease in childhood. We prospectively evaluated... 
Original Article | CHRONIC MYELOGENOUS LEUKEMIA | TOTAL-BODY IRRADIATION | adolescents | stem cell transplantation | BONE-MARROW-TRANSPLANTATION | UNRELATED DONORS | EUROPEAN GROUP | Chronic myeloid leukemia | WORKING PARTY | CHRONIC MYELOID-LEUKEMIA | INTERFERON-ALPHA | children | FRENCH-SOCIETY | PEDIATRICS | PATIENTS RECEIVING IMATINIB
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 10/2012, Volume 26, Issue 10, pp. 901 - 907
Journal Article